Patent US5088978A successfully refreshed from Google Patents.
US5088978A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Apparatus and method for iontophoretic transfer
Assignee: Sicor Inc
•
Filing: 1990-01-26
•
Granted: 1992-02-18
•
Expires: 2010-01-26
Abstract
Abstract An apparatus and method for iontophoretic transdermal delivery of exercise simulating agents includes an electrode having disposed therein a drug reservoir comprising a viscosity-control agent comprising an aqueous sol with an antioxidant, a preservative, a chelator and a buffer. A silver/silver chloride conducive element is preferably situated in the electrode adjacent the drug reservoir to conduct an electric charge across the reservoir.
Inventors
- 👤 Robert S. Hillman
- 👤 John M. Pawelchak
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 18:03
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/0404; A61N1/0408; A61N1/0428; A61N1/0448
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
74 words
A transdermal iontophoretic drug delivery system for delivering an exercise simulating agent comprising: an electrode including a metallic conductive element, and a gel reservoir, the gel reservoir being disposed adjacent to the metallic conductive element, and a gel disposed in the gel reservoir including a catecholamine analog as an exercise stimulating agent, a viscosity-control agent comprising hydroxypropyl methylcellulose dispersed to form an aqueous sol with an antioxidant, a preservative, a chelator and a buffer.
Claim 2
Dependent Claim
74 words
A transdermal iontophoretic drug delivery system for delivering an exercise simulating agent comprising: an electrode including a metallic conductive element, and a gel reservoir, the gel reservoir being disposed adjacent to the metallic conductive element, and a gel disposed in the gel reservoir including a catecholamine analog as an exercise stimulating agent, a viscosity-control agent comprising hydroxypropyl methylcellulose dispersed to form an aqueous sol with an antioxidant, a preservative, a chelator and a buffer.
Claim 3
Dependent Claim
18 words
The delivery system set forth in claim 1 wherein said viscosity control agent is METHOCEL® (hydroxypropyl methylcellulose) E10M.
Claim 4
Dependent Claim
46 words
The delivery system set forth in claim 1 wherein said viscosity control agent is METHOCEL® (hydroxypropyl methylcellulose) E10M, said antioxidant is sodium metabisulfite, said preservative is a mixture of methyl and propyl parabens, said chelator is disodium salt of EDTA, and said buffer is citric acid/citrate.
Claim 5
Dependent Claim
39 words
The delivery system set forth in claim 1 comprising 4-10% (w/v) hydroxypropyl methylcellulose, 0.1-10% (w/v) sodium metabisulfite, 0.001-0.05% (w/v) disodium salt of EDTA, 0.001-0.05M citric acid/citrate, 0.10-0.20% (w/v) parabens which comprises a mixture of methyl and 0.02-0.04% (w/v) propyl.
Claim 6
Dependent Claim
16 words
The transdermal iontophoretic drug delivery system of claim 1 wherein the metallic conductive element includes silver.
Claim 7
Dependent Claim
17 words
The transdermal iontophoretic drug delivery system of claim 5 wherein the metallic conductive element is silver/silver chloride.
Claim 8
Dependent Claim
69 words
A transdermal iontophoretic drug delivery system for delivering GP-2-121-3 comprising: an electrode including a metallic conductive element, and a reservoir adjacent to the metallic conductive element, a gel disposed in the reservoir including GP-2-121-3, a viscosity control agent comprising 4-10% (w/v) hydroxypropyl methylcellulose, 0.1-10% (w/v) sodium metabisulfite, 0.0001-0.05% (w/v) disodium salt of EDTA, 0.005-0.05M citric acid/citrate, 0.10-0.20% (w/v) parabens which comprises a mixture of methyl and 0.02-0.04% (w/v) propyl.
Claim 9
Dependent Claim
69 words
A transdermal iontophoretic drug delivery system for delivering GP-2-121-3 comprising: an electrode including a metallic conductive element, and a reservoir adjacent to the metallic conductive element, a gel disposed in the reservoir including GP-2-121-3, a viscosity control agent comprising 4-10% (w/v) hydroxypropyl methylcellulose, 0.1-10% (w/v) sodium metabisulfite, 0.0001-0.05% (w/v) disodium salt of EDTA, 0.005-0.05M citric acid/citrate, 0.10-0.20% (w/v) parabens which comprises a mixture of methyl and 0.02-0.04% (w/v) propyl.
Claim 10
Dependent Claim
22 words
The delivery system set forth in claim 7 further including a silver/silver chloride conductive element disposed in adjacent engagement with said reservoir.
Claim 11
Dependent Claim
40 words
The delivery system set forth in claim 8 further including an indifferent electrode comprising a reservoir having disposed therein 4-10% (w/v) hydroxypropyl methylcellulose, 0.1-0.5% sodium chloride, 0.10-0.20% (w/v) parabens, 0.10-0.20% (w/v) Sodium H 2 PO 4 and 80-95% (w/v) water.
Claim 12
Independent Claim
127 words
A method for iontophoretically delivering a catecholamine amino isopropanol exercise simulating agent comprising applying to a patient's skin a first electrode comprising a reservoir containing a substance to be iontophoretically delivered, said reservoir further comprising a viscosity control agent comprising 4-10% (w/v) hydroxypropyl methylcellulose, 0.1-10% (w/v) sodium metabisulfite, 0.001-0.05% (w/v) disodium salt of EDTA, 0.005-0.05M citric acid/citrate, 0.10-0.20% (w/v) parabens which comprises a mixture of methyl and 0.02-0.04% (w/v) propyl, said method further comprising securing a second electrode to the patient a short distance from said first electrode, said second electrode comprising a gel reservoir having disposed therein 4-10% (w/v) hydroxypropyl methylcellulose, 0.1-0.5% sodium chloride, 0.10-0.20% (w/v) parabens, 0.10-0.20% (w/v) Sodium H 2 PO 4 and 80-95% (w/v) water, and applying an electrical potential across said electrodes.
Claim 13
Independent Claim
127 words
A method for iontophoretically delivering a catecholamine amino isopropanol exercise simulating agent comprising applying to a patient's skin a first electrode comprising a reservoir containing a substance to be iontophoretically delivered, said reservoir further comprising a viscosity control agent comprising 4-10% (w/v) hydroxypropyl methylcellulose, 0.1-10% (w/v) sodium metabisulfite, 0.001-0.05% (w/v) disodium salt of EDTA, 0.005-0.05M citric acid/citrate, 0.10-0.20% (w/v) parabens which comprises a mixture of methyl and 0.02-0.04% (w/v) propyl, said method further comprising securing a second electrode to the patient a short distance from said first electrode, said second electrode comprising a gel reservoir having disposed therein 4-10% (w/v) hydroxypropyl methylcellulose, 0.1-0.5% sodium chloride, 0.10-0.20% (w/v) parabens, 0.10-0.20% (w/v) Sodium H 2 PO 4 and 80-95% (w/v) water, and applying an electrical potential across said electrodes.
References Cited (Backward Citations)
US3027333A
Cited
US3567657A
Cited
US3989050A
Cited
US4406827A
Cited
US4362165A
Cited
EP0058920A1
Cited
US4702732A
Cited
GB2184016A
Cited
US4842577A
Cited
US4927408A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-02-17 | 1995-08-19 | 1996-02-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-02-17 | 1999-08-19 | 2000-02-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-02-17 | 2003-08-19 | 2004-02-18 | $7700.00 | Window Closed / Lapsed |